drugset / Trial / NCT00403988

Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma

NCT00403988 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Study Objective : To assess the efficacy and the safety of the combination of Oxaliplatin, and Vinorelbine with or without Trastuzumab as a salvage regimen in patients with Metastatic Breast Cancer

Timeline

Start
2004-06
Primary completion
—
Completion
2007-12

Outcome

Outcome not reported

Stopped: “The results of a same study design have shown low response with important side effects. Accordingly \& ethicly, the study has been stopped.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule — —
Subject Vinorelbine Small molecule — —

Indications